- Report
- August 2024
- 150 Pages
Global
From €2564EUR$2,789USD£2,180GBP
- Report
- August 2024
- 150 Pages
Global
From €2564EUR$2,789USD£2,180GBP
- Report
- May 2024
- 140 Pages
Global
From €4549EUR$4,949USD£3,868GBP
- Report
- September 2023
- 160 Pages
Global
From €3308EUR$3,599USD£2,813GBP
- Report
- April 2023
- 147 Pages
Global
From €4549EUR$4,949USD£3,868GBP
- Report
- April 2023
- 147 Pages
Global
From €4549EUR$4,949USD£3,868GBP
- Report
- February 2024
- 179 Pages
Global
From €2758EUR$3,000USD£2,345GBP
- Report
- September 2023
- 115 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- July 2023
- 119 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- February 2025
- 233 Pages
Global
From €2298EUR$2,500USD£1,954GBP
- Report
- January 2025
- 199 Pages
Global
From €2298EUR$2,500USD£1,954GBP
- Report
- July 2024
- 150 Pages
Global
From €3447EUR$3,750USD£2,931GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1838EUR$2,000USD£1,563GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1838EUR$2,000USD£1,563GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1838EUR$2,000USD£1,563GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1838EUR$2,000USD£1,563GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1379EUR$1,500USD£1,172GBP
- Report
- July 2024
- 150 Pages
Global
From €3447EUR$3,750USD£2,931GBP
- Report
- June 2024
- 200 Pages
Global
From €7308EUR$7,950USD£6,213GBP
- Report
- June 2026
- 122 Pages
Mexico
From €2757EUR$2,999USD£2,344GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more